Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exozymes (EXOZ) Free Cash Flow (2023 - 2024)

Exozymes (EXOZ) has disclosed Free Cash Flow for 2 consecutive years, with -$5.9 million as the latest value for Q4 2024.

  • Quarterly Free Cash Flow fell 562.69% to -$5.9 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was -$8.9 million through Dec 2024, changed N/A year-over-year, with the annual reading at -$6.7 million for FY2025, 25.05% up from the prior year.
  • Free Cash Flow for Q4 2024 was -$5.9 million at Exozymes, down from -$541524.0 in the prior quarter.
  • The five-year high for Free Cash Flow was $132391.0 in Q1 2024, with the low at -$5.9 million in Q4 2024.